Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed to accelerate one of the slowest and most challenging stages of cancer drug ...
A new prototype could supercharge mass spectrometry by analyzing thousands of molecules at once instead of one by one. The breakthrough boosts sensitivity enough to reveal rare, hidden ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results